Community cardiology specialist Dr Peter Savill discusses five key challenges for GPs in the management of atrial ...

The global market for prosthetic heart valve is forecasted to attain USD 15,294.6 million by 2025, expanding at 7.5% CAGR to reach USD 31,522.6 million by 2035. In 2024, the revenue of prosthetic ...

Researchers used PET/MRI to detect otherwise invisible inflammation. Less clear is how this might influence patient care.

Nyra Medical, a leading innovator in structural heart therapies, today announced two key executive appointments that further solidify the company's momentum as it advances its revolutionary Cardiac ...

Mitral valve. Located between the left atrium and the left ... This procedure is helpful in determining the type and extent of certain valve disorders. Magnetic resonance imaging (MRI). This test uses ...

There was considerable variation in the intervals from Q to mitral valve closure (Q-MVC) and from Q to peak dA/dt and in the isovolumic contraction time between normal subjects. There was no ...

Approximately 10% of people ≥75 years of age have significant MR; these patients have decreased survival regardless of whether MR is a consequence of a primary mitral valve abnormality or secondary to ...

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...

The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...